transitioning from tirzepatide to semaglutide Early Dose Escalation of after Switching in Type 2 Diabetes Mellitus going from tirzepatide to semaglutide
Description
They start too high, increase too fast, or stay too long at a dose that isnt moving the needle anymore
Most patients report eating 3040% fewer calories without conscious effort during this early phase
Moreover, we recently demonstrated that activating GLP-1 receptor by exendin-4 treatment enhances the expression of NAMPT, SIRT1, and AMPK in mouse liver
Add therapy
The combination of lower estrogen and age-related muscle loss reduces the body's ability to manage blood sugar efficiently
The glucagon component may also contribute to reduced hepatic lipid accumulation, which improves hepatic insulin sensitivity over time
